Killing a cancer: what are the alternatives?
- PMID: 22576162
- DOI: 10.1038/nrc3264
Killing a cancer: what are the alternatives?
Abstract
Evading programmed cell death is one of the hallmarks of cancer. Conversely, inducing cell death by pharmacological means is the basis of almost every non-invasive cancer therapy. Research over the past decade has greatly increased our understanding of non-apoptotic programmed cell death events, such as lysosomal-mediated cell death, necroptosis and cell death with autophagy. It is becoming clear that an intricate effector network connects many of these classical and non-classical death pathways. In this Review, we discuss converging and diverging features of these pathways, as well as attempts to exploit this newly gained knowledge pharmacologically to provide therapeutics for cancer.
Similar articles
-
Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy.Oncotarget. 2016 Aug 30;7(35):57391-57413. doi: 10.18632/oncotarget.10548. Oncotarget. 2016. PMID: 27429198 Free PMC article. Review.
-
Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and RIPK3 proteins and potentiation of necroptosis.Cell Death Dis. 2018 May 1;9(5):476. doi: 10.1038/s41419-018-0469-1. Cell Death Dis. 2018. PMID: 29686269 Free PMC article.
-
The role of necroptosis, an alternative form of cell death, in cancer therapy.Expert Rev Anticancer Ther. 2013 Jul;13(7):883-93. doi: 10.1586/14737140.2013.811180. Expert Rev Anticancer Ther. 2013. PMID: 23875666 Review.
-
Molecular Cell Biology of Apoptosis and Necroptosis in Cancer.Adv Exp Med Biol. 2016;930:1-23. doi: 10.1007/978-3-319-39406-0_1. Adv Exp Med Biol. 2016. PMID: 27558815 Review.
-
Membrane-bound TNF mediates microtubule-targeting chemotherapeutics-induced cancer cytolysis via juxtacrine inter-cancer-cell death signaling.Cell Death Differ. 2020 May;27(5):1569-1587. doi: 10.1038/s41418-019-0441-3. Epub 2019 Oct 23. Cell Death Differ. 2020. PMID: 31645676 Free PMC article.
Cited by
-
Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis.Oncotarget. 2015 Jan 30;6(3):1640-51. doi: 10.18632/oncotarget.2746. Oncotarget. 2015. PMID: 25682199 Free PMC article.
-
Damage-associated molecular patterns in cancer: a double-edged sword.Oncogene. 2016 Nov 17;35(46):5931-5941. doi: 10.1038/onc.2016.104. Epub 2016 Apr 18. Oncogene. 2016. PMID: 27086930 Free PMC article. Review.
-
An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients.Aging (Albany NY). 2020 Aug 29;12(15):15624-15637. doi: 10.18632/aging.103718. Aging (Albany NY). 2020. PMID: 32805727 Free PMC article.
-
Derivatives of 6-cinnamamido-quinoline-4-carboxamide impair lysosome function and induce apoptosis.Oncotarget. 2016 Jun 21;7(25):38078-38090. doi: 10.18632/oncotarget.9348. Oncotarget. 2016. PMID: 27191263 Free PMC article.
-
Regulated cell death (RCD) in cancer: key pathways and targeted therapies.Signal Transduct Target Ther. 2022 Aug 13;7(1):286. doi: 10.1038/s41392-022-01110-y. Signal Transduct Target Ther. 2022. PMID: 35963853 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous